Jennifer Fox is the founder of Nuvation Bio. Nuvation Bio has raised $275M in total funding. Latest round: Series A. Based in New York, United States.
Jennifer Fox is the Chief Financial Officer at Nuvation Bio, an oncology treatments company focused on developing new generations of medicines to improve patient lives by addressing drug resistance or limited efficacy of current therapies. The company has raised $275 million in Series A financing. Prior to joining Nuvation Bio, she was a leader in healthcare investment banking.
Full founder directory · Investor directory · Company funding database · Fundraising library